Charles Schwab Investment Management Inc Neuronetics, Inc. Transaction History

Charles Schwab Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $114,471 - $203,200	-54,771 Reduced 79.83%	13,837 $45,000
Q1 2022 May 13, 2022	BUY	$2.84 - $4.52 $5,146 - $8,190	1,812 Added 2.71%	68,608 $208,000
Q3 2021 Nov 16, 2021	BUY	$6.22 - $15.54 $30,882 - $77,156	4,965 Added 8.03%	66,796 $439,000
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $627,584 - $1.07 Million	61,831 New	61,831 $991,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.61 $52,105 - $96,449	-36,954 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$8.31 - $13.03 $73,726 - $115,602	8,872 Added 31.59%	36,954 $308,000
Q2 2019 Aug 09, 2019	BUY	$9.0 - $17.2 $3,987 - $7,619	443 Added 1.6%	28,082 $352,000
Q1 2019 May 14, 2019	BUY	$13.6 - $19.58 $186,986 - $269,205	13,749 Added 98.98%	27,639 $422,000
Q3 2018 Nov 13, 2018	BUY	$24.32 - $37.54 $337,804 - $521,430	13,890 New	13,890 $446,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $40.8M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.